Are 'Not-for-Profits' providing a reasonable level of defined community benefits?
Apr 1, 2008
By:
Charles J. Lockwood, MD
|
Are 'Not-for-Profits' providing a reasonable level of defined community benefits?
Patients taking bisphosphonates may develop severe and sometimes incapacitating musculoskeletal pain.
Desvenlafaxine succinate, a serotonin norepinephrine reuptake inhibitor (SNRI), reduces hot flashes by about 64% after 3 months of use, according to the results of a double-blind, placebo-controlled trial.
With no clear-cut set of signs and symptoms to advertise its presence, experts suggest diagnosis may require MRI, transvaginal U/S, and/or needle biopsy. Among your treatment options: hysterectomy, GnRH agonists, and the levonorgestrel IUD.
Feb 1, 2008
By:
Priya Maseelall, MD, Gerson Weiss, MD
|
With no clear-cut set of signs and symptoms to advertise its presence, experts suggest diagnosis may require MRI, transvaginal U/S, and/or needle biopsy. Among your treatment options: hysterectomy, GnRH agonists, and the levonorgestrel IUD.
Almost half of all original pathology reports that analyzed tissue to confirm endometrial cancer contain significant discrepancies, when compared with formal pathology reviews.
Consider a history of preeclampsia when calculating your patients' risk for cardiovascular disease.
Women who have been treated for cervical intraepithelial neoplasia grade 3 (CIN3) remain at increased risk for cervical and vaginal cancers as much as 25 years after treatment and should continue to be screened beyond current age recommendations for the general population.
Vaginal group B streptococcus (GBS) colony counts fall quickly and dramatically with intrapartum doses of penicillin-G.
Postmenopausal women who've taken hormone therapy have a lower risk of non-small-cell lung cancer (NSCLC) and particularly estrogen receptor-positive tumors.
